TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/24 19:32 | 4/4/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.d | -14 | 2.62 | 0 | -5 | 0 | 8,592 | D | ||||||||||||||
6/16/23 18:40 | 6/15/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.dm | -1,252 | 20.86 | 0 | -60 | -59 | 42 | D | ||||||||||||||
5/24/23 16:37 | 5/22/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S | -168 | 25.79 | 0 | -7 | -14 | 39 | D | ||||||||||||||
3/22/23 19:30 | 3/20/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.dm | -1,223 | 18.97 | 0 | -65 | -1 | 8,565 | D | ||||||||||||||
12/19/22 20:00 | 12/15/22 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DOT | CEO,P | S.dm | -1,181 | 19.69 | 0 | -60 | -1 | 8,559 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |